Cargando…
Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites
Mutations that increase the protein kinase activity of LRRK2 are one of the most common causes of familial Parkinson's disease. LRRK2 phosphorylates a subset of Rab GTPases within their Switch-II motif, impacting interaction with effectors. We describe and validate a new, multiplexed targeted m...
Autores principales: | Nirujogi, Raja S., Tonelli, Francesca, Taylor, Matthew, Lis, Pawel, Zimprich, Alexander, Sammler, Esther, Alessi, Dario R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833208/ https://www.ncbi.nlm.nih.gov/pubmed/33367571 http://dx.doi.org/10.1042/BCJ20200930 |
Ejemplares similares
-
Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms
por: Malik, Asad U., et al.
Publicado: (2021) -
The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
por: Dzamko, Nicolas, et al.
Publicado: (2012) -
Inhibition of LRRK2 kinase activity leads to dephosphorylation of
Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic
localization
por: Dzamko, Nicolas, et al.
Publicado: (2010) -
Lack of Correlation between the Kinase Activity of LRRK2 Harboring Kinase-Modifying Mutations and Its Phosphorylation at Ser910, 935, and Ser955
por: Ito, Genta, et al.
Publicado: (2014) -
Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity
por: Kalogeropulou, Alexia F., et al.
Publicado: (2020)